DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹6,393 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹507,872 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹6,393 Cr |
| Mar2025 | ₹5,639 Cr |
| Mar2024 | ₹5,398 Cr |
| Mar2023 | ₹507,872 Cr |
| Mar2022 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,393 Cr | 13.37 | |
| Mar2025 | ₹5,639 Cr | 4.46 | |
| Mar2024 | ₹5,398 Cr | -98.94 | |
| Mar2023 | ₹507,872 Cr | 12,261.98 | |
| Mar2022 | ₹4,108 Cr | - | |
Compare Total Expenditure of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹240,010.7 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
| MANKIND PHARMA | ₹97,263.9 Cr | -2.9% | 2.3% | -3.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.8% |
-3.2% |
51.5% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses